However, the few studies focusing on complement levels in pregnant women with SLE and/or APS have not yet provided a clear-cut evidence of their clinical significance; nevertheless, the current practice considers low C3 and C4 as prognostic marker of obstetric unfavorable outcome. This evidence concerns the gene C4A and systemic lupus erythematosus.